Netrin-1 receptor-deficient mice show enhanced mesocortical dopamine transmission and blunted behavioural responses to amphetamine

Eur J Neurosci. 2007 Dec;26(11):3215-28. doi: 10.1111/j.1460-9568.2007.05888.x. Epub 2007 Nov 14.

Abstract

The mesocorticolimbic dopamine (DA) system is implicated in neurodevelopmental psychiatric disorders including schizophrenia but it is unknown how disruptions in brain development modify this system and increase predisposition to cognitive and behavioural abnormalities in adulthood. Netrins are guidance cues involved in the proper organization of neuronal connectivity during development. We have hypothesized that variations in the function of DCC (deleted in colorectal cancer), a netrin-1 receptor highly expressed by DA neurones, may result in altered development and organization of mesocorticolimbic DA circuitry, and influence DA function in the adult. To test this hypothesis, we assessed the effects of reduced DCC on several indicators of DA function. Using in-vivo microdialysis, we showed that adult mice that develop with reduced DCC display increased basal DA levels in the medial prefrontal cortex and exaggerated DA release in response to the indirect DA agonist amphetamine. In contrast, these mice exhibit normal levels of DA in the nucleus accumbens but significantly blunted amphetamine-induced DA release. Concomitantly, using conditioned place preference, locomotor activity and prepulse inhibition paradigms, we found that reduced DCC diminishes the rewarding and behavioural-activating effects of amphetamine and protects against amphetamine-induced deficits in sensorimotor gating. Furthermore, we found that adult DCC-deficient mice exhibit altered dendritic spine density in layer V medial prefrontal cortex pyramidal neurones but not in nucleus accumbens medium spiny neurones. These findings demonstrate that reduced DCC during development results in a behavioural phenotype opposite to that observed in developmental models of schizophrenia and identify DCC as a critical factor in the development of DA function.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amphetamine / pharmacology*
  • Animals
  • Behavior, Animal / drug effects*
  • Behavior, Animal / physiology
  • Chromatography, High Pressure Liquid / methods
  • Conditioning, Operant / drug effects
  • Conditioning, Operant / physiology
  • DCC Receptor
  • Dopamine / metabolism*
  • Dopamine Uptake Inhibitors / pharmacology*
  • Dose-Response Relationship, Drug
  • Female
  • Male
  • Mice
  • Mice, Knockout
  • Microdialysis / methods
  • Neural Inhibition / drug effects
  • Neural Inhibition / physiology
  • Neurons / drug effects
  • Neurons / metabolism
  • Neurons / ultrastructure
  • Prefrontal Cortex / cytology
  • Prefrontal Cortex / drug effects*
  • Prefrontal Cortex / metabolism
  • Receptors, Cell Surface / deficiency*
  • Sex Factors
  • Silver Staining / methods
  • Tumor Suppressor Proteins / deficiency*
  • Tyrosine 3-Monooxygenase / metabolism

Substances

  • DCC Receptor
  • Dcc protein, mouse
  • Dopamine Uptake Inhibitors
  • Receptors, Cell Surface
  • Tumor Suppressor Proteins
  • Amphetamine
  • Tyrosine 3-Monooxygenase
  • Dopamine